Sana Biotechnology, Inc. SANA
- SG293 Preclinical
- SG227 — Multiple Myeloma Preclinical
- SG293 — Non-Hodgkin Lymphoma Preclinical
CD8 (1 companies · 3 programs)
Companies with an active program directed at CD8.
Companies with an active program directed at CD8.